Table 6.
Sensitivity analysis results
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Total (5 years results) | |
|---|---|---|---|---|---|---|
| Base scenario | ||||||
| Vaccine BI (USD) | 8,868,921 | 9,312,367 | 9,843,172 | 10,473,135 | 11,216,727 | 49,714,322 |
| Hib disease care BI (USD) | -971,227 | -1,141,192 | -1,272,162 | -1,394,245 | -1,502,559 | -6,281,387 |
| Net BI (USD) | 7,897,693 | 8,171,174 | 8,571,009 | 9,078,889 | 9,714,167 | 43,432,934 |
| Second scenario | ||||||
| Vaccine BI (USD) | 8,868,921 | 9,940,023 | 11,269,731 | 12,577,727 | 14,222,115 | 56,878,518 |
| Hib disease care BI (USD) | -971,227 | -1,278,135 | -1,595,800 | -1,958,814 | -2,364,306 | -8,168,285 |
| Net BI (USD) | 7,897,693 | 8,661,887 | 9,673,930 | 10,618,913 | 11,857,808 | 48,710,233 |
| Third scenario | ||||||
| Vaccine BI (USD) | 8,868,921 | 9,940,023 | 11,269,731 | 12,577,727 | 14,222,115 | 56,878,518 |
| Hib disease care BI (USD) | -1,204,777 | -1,585,487 | -1,979,541 | -2,429,848 | -2,932,849 | -10,132,504 |
| Net BI (USD) | 7,664,143 | 8,354,535 | 9,290,189 | 10,147,879 | 11,289,266 | 46,746,014 |
| Fourth scenario | ||||||
| Vaccine BI (USD) | 9,183,753 | 10,293,241 | 11,670,517 | 13,025,331 | 14,728,569 | 58,901,414 |
| Hib disease care BI (USD) | -971,227 | -1,278,135 | -1,595,800 | -1,958,814 | -2,364,306 | -8,168,285 |
| Net BI (USD) | 8,212,525 | 9,015,105 | 10,074,716 | 11,066,517 | 12,364,262 | 50,733,128 |
BI Budget Impact, USD United States Dollars